Fundamental Step Found in the Cellular Response to Stress Caused by Pathological and Pharmacological Insults
PHILADELPHIA - (March 6, 2018) - A new study conducted by researchers at The Wistar Institute revealed how a key protein residing in the endoplasmic reticulum (ER) helps cells respond to stress. This process is especially important for B cells to respond to severe stress conditions and their ability to produce antibodies. The research was published online in the Journal of Cell Biology.
The ER is a cellular structure where protein production, folding and assembly occur. It harbors complex mechanisms to supervise these processes and respond to the stress caused by the accumulation of misfolded proteins resulting from a number of pathological and pharmacological causes.
IRE1 is a transmembrane protein that senses ER stress and responds by activating two cascades of cellular events. IRE1 regulates the maturation of the XBP1 mRNA to produce the functional XBP1 transcription factor, which in turn bolsters the expression of target genes encoding for chaperone proteins that resolve the accumulation of misfolded proteins. IRE1 can also engage a mechanism called regulated IRE1-dependent decay (RIDD) by cleaving a subset of messenger RNAs to reduce the load of proteins coming into the ER until the crisis is resolved. IRE1 function is especially critical in B cells since the ER plays a central role in the biogenesis of antibodies. However, the molecular mechanism that regulates the RIDD function of IRE1 remained unclear.
In the study, Chih-Chi Andrew Hu, Ph.D., associate professor in Wistar's Immunology, Microenvironment & Metastasis Program, and colleagues characterized a novel phosphorylation that regulates IRE1 to perform RIDD in response to specific ER stress conditions.
"Our results showed that this phosphorylation is critical for IRE1 function during production of antibodies in response to immunization," said Chih-Hang Anthony Tang, Ph.D., a staff scientist in the Hu Lab and first author of the study.
The researchers specifically examined the status of the IRE1 protein in XBP1-deficients cells and discovered the phosphorylation at Ser729 of IRE1. They then extensively characterized the function of this phosphorylation by creating an antibody that specifically recognizes IRE1 when phosphorylated in that particular site. They also generated a knock-in mouse model that expresses a mutant IRE1 that cannot undergo phosphorylation to study the consequences of its absence.
"Deepening our understanding of a fundamental player in the ER stress response will provide us with useful tools to interrogate the biology of ER stress response in human pathological conditions, including metabolic, neurodegenerative, immune disease and cancer," Hu said.
This work was supported by National Institutes of Health grants R01CA163910, R21CA199553, R01CA190860, and R01CA100062. Core support for The Wistar Institute was provided by the Cancer Center Support Grant P30 CA010815.
Co-authors from Wistar include Shiun Chang and Dmitry I. Gabrilovich. Other co-authors include Adrienne W. Paton and James C. Paton from the University of Adelaide, Australia, Hidde. L. Ploegh from Boston Children's Hospital, and Juan R. Del Valle from the University of South Florida.
The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the United States, Wistar has held the prestigious Cancer Center designation from the National Cancer Institute since 1972. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. wistar.org.